NCT07889934Completed
Enhanced Recovery After Surgery in Patients Undergoing Colorectal Cancer Surgery
Impact of an Enhanced Recovery After Surgery (ERAS) Protocol on Postoperative Recovery in Patients Undergoing Surgery for Colorectal Cancer
Source: ClinicalTrials.gov · Last updated 2 Nov 2026
Brief summary (registry, in English)
This study compared an Enhanced Recovery After Surgery (ERAS) care program with conventional perioperative care in adults undergoing surgery for colorectal cancer. Participants received either ERAS care or usual care. The ERAS program included coordinated measures before, during, and after surgery aimed at supporting faster and safer recovery. The study evaluated whether ERAS was associated with a shorter length of hospital stay and improved postoperative recovery. Other outcomes included early mobilization, return of bowel function and oral feeding, postoperative pain, complications and adverse events, removal of urinary catheters and drains, discontinuation of intravenous therapy, and selected laboratory measures. The study was conducted at the General Anticancer Oncology Hospital of Athens "Saint Savvas" in Greece.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 91 (actual)
- First submitted
- 18 Oct 2026
- Start date
- 17 Sept 2024
- Primary completion date
- 25 Jun 2025
- Lead sponsor
- University of West Attica
- Diseases
- Colorectal cancer
- NCT number
- NCT07889934
What you commit to
- Study type: Interventional
- Participants enrolled: 91
- From 17 Sept 2024 to the primary completion date, 25 Jun 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Current use of antidepressant medication (moclobemide, paroxetine, sertraline, citalopram, fluoxetine, fluvoxamine, venlafaxine, mirtazapine).
Other illness
- Acute or chronic renal disease.
- Acute or chronic hepatic disease.
Other
- Current treatment for chronic pain.
Who the study is looking for
- Age 18 years or older.
- Diagnosis of colorectal cancer.
- Scheduled to undergo surgical resection of the colorectal tumor.
- Ability to understand and communicate in Greek.
- Sufficient cognitive capacity to understand the study information, provide informed consent, and participate in the study procedures.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| General Anticancer Oncology Hospital of Athens "Saint Savvas" Coordinator of this site? Confirm its status | Athens | Greece | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.